Literature DB >> 29031689

Oral administration of kaempferol inhibits bone loss in rat model of ovariectomy-induced osteopenia.

Beata Nowak1, Agnieszka Matuszewska2, Anna Nikodem3, Jarosław Filipiak3, Marcin Landwójtowicz4, Ewa Sadanowicz4, Diana Jędrzejuk4, Marta Rzeszutko5, Krzysztof Zduniak5, Tomasz Piasecki6, Przemysław Kowalski7, Wojciech Dziewiszek2, Anna Merwid-Ląd2, Małgorzata Trocha2, Tomasz Sozański2, Joanna Kwiatkowska2, Marek Bolanowski4, Adam Szeląg2.   

Abstract

BACKGROUND: Postmenopausal osteoporosis and osteoporotic fractures constitute an increasing problem in developing countries. Kaempferol, isolated from seeds of Cuscuta chinensis, is an active flavonoid inhibiting in vitro osteoclast activity. The aim of the presented research was an assessment of kaempferol effect on estrogen-deficiency-induced bone structure disturbances in rats.
METHODS: The study was performed on 24 Wistar female rats divided into 3 groups: SHAM - rats undergoing a "sham" surgery, OVX-C - control group of animals that underwent ovariectomy, OVX-K - rats undergoing ovariectomy and receiving kaempferol for 8 weeks (from day 56 to day 112).
RESULTS: In the OVX-K group, contrary to the OVX-C one, there was no significant decrease in femoral bone mineral density (BMD). A significant increase in Young's modulus was observed in the OVX-K group compared to the OVX-C (15.33±2.51GPa vs. 11.14±1.93GPa, p<0.05). A decreased bone turnover was detected in the OVX-K group. Tissue volume ratio (BV/TV) and trabecular bone perimeter were increased in the OVX-K group compared to the OVX-C one (0.241±0.037 vs. 0.170±0.022, p<0.05 and 15.52±2.78mm vs. 9.67±3.07mm, p<0.05, respectively).
CONCLUSION: Kaempferol has a beneficial influence on estrogen-deficiency-induced disturbances of bone structure in rats.
Copyright © 2017 Institute of Pharmacology, Polish Academy of Sciences. Published by Elsevier Urban & Partner Sp. z o.o. All rights reserved.

Entities:  

Keywords:  Bone histomorphometry; Bone mechanical properties; Bone mineral density (BMD); Bone turnover; Kaempferol; Rats

Mesh:

Substances:

Year:  2017        PMID: 29031689     DOI: 10.1016/j.pharep.2017.05.002

Source DB:  PubMed          Journal:  Pharmacol Rep        ISSN: 1734-1140            Impact factor:   3.024


  11 in total

Review 1.  The Osteoprotective Effects Of Kaempferol: The Evidence From In Vivo And In Vitro Studies.

Authors:  Sok Kuan Wong; Kok-Yong Chin; Soelaiman Ima-Nirwana
Journal:  Drug Des Devel Ther       Date:  2019-10-07       Impact factor: 4.162

2.  Kaempferol promotes bone formation in part via the mTOR signaling pathway.

Authors:  Jing Zhao; Jue Wu; Binwu Xu; Zhen Yuan; Yu Leng; Jun Min; Xiaoyong Lan; Jun Luo
Journal:  Mol Med Rep       Date:  2019-10-16       Impact factor: 2.952

3.  Osseointegration Effect of Micro-Nano Implants Loaded With Kaempferol in Osteoporotic Rats.

Authors:  Anyue Wang; Wenhong Yuan; Yu Song; Yanjun Zang; Yanling Yu
Journal:  Front Bioeng Biotechnol       Date:  2022-02-23

4.  Research on the Mechanism of Kaempferol for Treating Senile Osteoporosis by Network Pharmacology and Molecular Docking.

Authors:  Fuyu Tang; Peng Zhang; Wenhua Zhao; Guangye Zhu; Gengyang Shen; Honglin Chen; Xiang Yu; Zhida Zhang; Qi Shang; Xiaobing Jiang; Hui Ren
Journal:  Evid Based Complement Alternat Med       Date:  2022-02-03       Impact factor: 2.629

5.  A novel extraction method enhanced the osteogenic and anti-osteoporosis effect of tea extract without any hepatotoxicity in ovariectomized rats.

Authors:  Chirag Kulkarni; Shivani Sharma; Prateek Singh Bora; Saurabh Verma; Swati Rajput; Konica Porwal; Srikanta Kumar Rath; Jiaur Rahaman Gayen; Upendra Sharma; Naibedya Chattopadhyay
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-08       Impact factor: 6.055

6.  A Comparison of the Antiosteoporotic Effects of Cornelian Cherry (Cornus mas L.) Extracts from Red and Yellow Fruits Containing Different Constituents of Polyphenols and Iridoids in Osteoblasts and Osteoclasts.

Authors:  Eunkuk Park; Tomasz Sozański; Chang-Gun Lee; Alicja Z Kucharska; Dominika Przybylska; Narcyz Piórecki; Seon-Yong Jeong
Journal:  Oxid Med Cell Longev       Date:  2022-10-03       Impact factor: 7.310

Review 7.  Botanicals in Postmenopausal Osteoporosis.

Authors:  Wojciech Słupski; Paulina Jawień; Beata Nowak
Journal:  Nutrients       Date:  2021-05-11       Impact factor: 5.717

8.  Amaranthus mangostanus Inhibits the Differentiation of Osteoclasts and Prevents Ovariectomy-Induced Bone Loss.

Authors:  Yeon-Hui Jeong; Haeng Jeon Hur; Ae Sin Lee; Sang Hee Lee; Mi Jeong Sung
Journal:  Evid Based Complement Alternat Med       Date:  2020-02-07       Impact factor: 2.629

9.  Compounds Isolated from Wikstroemia taiwanensis Regulate Bone Remodeling by Modulating Osteoblast and Osteoclast Activities.

Authors:  Zuha Imtiyaz; Yi-Tzu Lin; Fang-Yu Liang; Wen-Fei Chiou; Mei-Hsien Lee
Journal:  Front Pharmacol       Date:  2021-07-13       Impact factor: 5.810

Review 10.  The Role of Macronutrients, Micronutrients and Flavonoid Polyphenols in the Prevention and Treatment of Osteoporosis.

Authors:  Monika Martiniakova; Martina Babikova; Vladimira Mondockova; Jana Blahova; Veronika Kovacova; Radoslav Omelka
Journal:  Nutrients       Date:  2022-01-25       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.